Ir a las transacciones
Salud

Procaps S.A. has raised funds

Procaps S.A. has closed a club deal bank facility in a transaction financed by Bancolombia S.A. and Banco Davivienda S.A. The funds will be designated for the refinancing of existing debts owed to current creditors. This strategic allocation will empower the company to navigate its growth plan with enhanced financial strength.

Procaps S.A. is a Colombian multinational firm, leader in the pharmaceutical market. The company develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and clinical solutions. Procaps distributes its products to 50 markets.

Oaklins’ team in Chile acted as the exclusive financial advisor to Procaps S.A. in this transaction.

Contáctese con el equipo de la transacción

Sebastián Cereceda

Socio
Santiago, Chile
Oaklins LarrainVial

Antonio Benvenuto

Asociado
Santiago, Chile
Oaklins LarrainVial

Transacciones relacionadas

Hemink Groep has been acquired by Gimv
Private Equity | Servicios de Construcción e Ingeniería | Real Estate

Hemink Groep has been acquired by Gimv

Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.

Aprenda más
The Providence Projects has been acquired by UKAT Group
Private Equity | Salud

The Providence Projects has been acquired by UKAT Group

Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.

Aprenda más
St. Claraspital AG has been acquired by University Hospital Basel
Salud

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

Aprenda más